[Artificial intravascular oxygenation (IVOX). Application to the treatment of postoperative respiratory failure].
Very recently, the concept of artificial intracorporeal oxygenation of blood for patients suffering from respiratory failure has been introduced into clinical practice through development of a totally implantable intravascular oxygenator (IVOX). We report on the use of such a device in a patient who developed severe respiratory insufficiency secondary to prolonged hypovolaemic shock and pneumonia following successful repair of a ruptured abdominal aortic aneurysm in September, 1990. Postoperatively, severe hypoxaemia occurred (AaDO2 548-602 torr) despite extensive mechanical ventilatory support. There was no obvious chance to overcome this situation by conventional therapeutic measures and the decision was made to institute IVOX therapy. Hypoxaemia was resolved immediately and both FiO2 and tidal volume could be reduced within hours. The patient's respiratory condition continued to improve over the next days leading to termination of IVOX therapy after 71 hours. However, the necessity of long-term ventilatory support secondary to recurrent pneumonia and sepsis, multiple abdominal reoperations for ischemic colitis and retroperitoneal abscess prolonged his recovery. He was discharged from the hospital after four months and is alive and well now 14 months after his operation. He is the first long-term survivor after IVOX therapy in Europe. IVOX may be successfully used in selected patients while the indications and it's potential role in the therapy of severe respiratory failure still need to be defined.
Jurmann
M J
MJ
Klinik für Thorax-, Herz- und Gefässchirurgie, Zentrum Chirurgie, Medizinische Hochschule Hannover.
Demertzis
S
S
Haverich
A
A
Laas
J
J
Meissner
E
E
Siclari
F
F
Borst
H G
HG
D006801:Humans; D008297:Male; D008875:Middle Aged; D010106:Oxygenators; D011183:Postoperative Complications / Q000628:therapy*; D019736:Prostheses and Implants; D012131:Respiratory Insufficiency / Q000628:therapy*
Artifizielle intravaskuläre Oxygenierung (IVOX). Zur Therapie des postoperativen Lungenversagens.